AVXL
Price
$10.79
Change
+$0.22 (+2.08%)
Updated
Jul 3 closing price
Capitalization
921.16M
37 days until earnings call
CRVO
Price
$5.65
Change
+$0.09 (+1.62%)
Updated
Jul 3 closing price
Capitalization
49.17M
Interact to see
Advertisement

AVXL vs CRVO

Header iconAVXL vs CRVO Comparison
Open Charts AVXL vs CRVOBanner chart's image
Anavex Life Sciences
Price$10.79
Change+$0.22 (+2.08%)
Volume$800.37K
Capitalization921.16M
CervoMed
Price$5.65
Change+$0.09 (+1.62%)
Volume$127.23K
Capitalization49.17M
AVXL vs CRVO Comparison Chart in %
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. CRVO commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a StrongBuy and CRVO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (AVXL: $10.79 vs. CRVO: $5.65)
Brand notoriety: AVXL and CRVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 88% vs. CRVO: 61%
Market capitalization -- AVXL: $921.16M vs. CRVO: $49.17M
AVXL [@Biotechnology] is valued at $921.16M. CRVO’s [@Biotechnology] market capitalization is $49.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileCRVO’s FA Score has 0 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • CRVO’s FA Score: 0 green, 5 red.
According to our system of comparison, both AVXL and CRVO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 6 TA indicator(s) are bullish while CRVO’s TA Score has 4 bullish TA indicator(s).

  • AVXL’s TA Score: 6 bullish, 4 bearish.
  • CRVO’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, both AVXL and CRVO are a good buy in the short-term.

Price Growth

AVXL (@Biotechnology) experienced а +12.75% price change this week, while CRVO (@Biotechnology) price change was -20.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

AVXL is expected to report earnings on Dec 22, 2025.

CRVO is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($921M) has a higher market cap than CRVO($49.2M). CRVO YTD gains are higher at: 141.453 vs. AVXL (0.466). CRVO has higher annual earnings (EBITDA): -20.94M vs. AVXL (-45.65M). AVXL has more cash in the bank: 116M vs. CRVO (35.2M). CRVO has less debt than AVXL: CRVO (0) vs AVXL (88.2K). AVXL (0) and CRVO (0) have equivalent revenues.
AVXLCRVOAVXL / CRVO
Capitalization921M49.2M1,872%
EBITDA-45.65M-20.94M218%
Gain YTD0.466141.4530%
P/E RatioN/A4.73-
Revenue00-
Total Cash116M35.2M330%
Total Debt88.2K0-
FUNDAMENTALS RATINGS
AVXL vs CRVO: Fundamental Ratings
AVXL
CRVO
OUTLOOK RATING
1..100
3350
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
38
Fair valued
PROFIT vs RISK RATING
1..100
76100
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
3763
P/E GROWTH RATING
1..100
10069
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRVO's Valuation (38) in the Biotechnology industry is in the same range as AVXL (62). This means that CRVO’s stock grew similarly to AVXL’s over the last 12 months.

AVXL's Profit vs Risk Rating (76) in the Biotechnology industry is in the same range as CRVO (100). This means that AVXL’s stock grew similarly to CRVO’s over the last 12 months.

AVXL's SMR Rating (96) in the Biotechnology industry is in the same range as CRVO (98). This means that AVXL’s stock grew similarly to CRVO’s over the last 12 months.

AVXL's Price Growth Rating (37) in the Biotechnology industry is in the same range as CRVO (63). This means that AVXL’s stock grew similarly to CRVO’s over the last 12 months.

CRVO's P/E Growth Rating (69) in the Biotechnology industry is in the same range as AVXL (100). This means that CRVO’s stock grew similarly to AVXL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLCRVO
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bullish Trend 4 days ago
88%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVIR3.740.11
+3.17%
Atea Pharmaceuticals
DTIL4.340.08
+1.88%
Precision BioSciences
SPSC141.361.42
+1.01%
SPS Commerce
JBGS17.070.16
+0.95%
JBG SMITH Properties
RATIY45.18N/A
N/A
Rational AG

CRVO and

Correlation & Price change

A.I.dvisor tells us that CRVO and TCRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRVO and TCRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVO
1D Price
Change %
CRVO100%
+1.62%
TCRX - CRVO
32%
Poorly correlated
+2.72%
LVTX - CRVO
29%
Poorly correlated
+0.76%
NKTR - CRVO
27%
Poorly correlated
-3.02%
AVXL - CRVO
27%
Poorly correlated
+2.08%
TRDA - CRVO
26%
Poorly correlated
N/A
More